WASHINGTON, Aug. 14 -- Food and Drug Administration has issued a notice called: Container Closure Systems for Human Drugs and Biological Products; Draft Guidance for Industry; Availability.
The notice was published in the Federal Register on Aug. 14 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry entitled "Container Closure Systems for Human Drugs and Biological Products." This document provides guiding principles for evaluating the quality of container closure systems (CCSs) used to package drugs and biological products, for human use. This includes CCSs that are also d...